Canada markets closed

Nymox Pharmaceutical Corporation (NYM.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
1.75000.0000 (0.00%)
At close: 08:29PM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
Total Revenue
-5
0
0
5
Cost of Revenue
0
0
0
4
Gross Profit
-5
0
0
1
Operating Expenses
Research Development
-289
3,773
6,658
8,120
Selling General and Administrative
2,103
2,879
5,846
3,601
Total Operating Expenses
1,814
6,652
12,504
11,721
Operating Income or Loss
-1,819
-6,652
-12,504
-11,720
Interest Expense
-
43
39
42
Total Other Income/Expenses Net
-
118
-2
-3
Income Before Tax
-4,872
-6,576
-12,537
-11,738
Income Tax Expense
0
0
0
0
Income from Continuing Operations
-4,872
-6,576
-12,537
-11,738
Net Income
-4,872
-6,576
-12,537
-11,738
Net Income available to common shareholders
-4,872
-6,576
-12,537
-11,738
Basic EPS
-
-
-
-0.16
Diluted EPS
-
-
-
-0.16
Basic Average Shares
-
-
-
73,823
Diluted Average Shares
-
-
-
73,823